We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$302M
AUM Growth
-$62.9M
Cap. Flow
-$78M
Cap. Flow %
-25.84%
Top 10 Hldgs %
21.72%
Holding
1,314
New
44
Increased
207
Reduced
571
Closed
197

Top Buys

Rank Stock Value
1
DE icon
Deere & Co
DE
+$481K
2
PYPL icon
PayPal
PYPL
+$408K
3
MCD icon
McDonald's
MCD
+$384K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$382K
5
SINA
Sina Corp
SINA
+$323K

Sector Composition

Rank Sector Weight
1 Technology 20.31%
2 Healthcare 12.61%
3 Financials 12.48%
4 Consumer Discretionary 8.71%
5 Energy 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRUS icon
426
Cirrus Logic
CRUS
$6.87B
$66.7K 0.02%
1,250
-1,100
-47% -$64.4K
D icon
427
Dominion Energy
D
$61.8B
$66.3K 0.02%
862
-2,065
-71% -$161K
PSEC icon
428
Prospect Capital
PSEC
$1.12B
$66.2K 0.02%
9,848
-791
-7% -$5.93K
PXD
429
DELISTED
Pioneer Natural Resource Co.
PXD
$65.7K 0.02%
446
-159
-26% -$22.9K
PML
430
PIMCO Municipal Income Fund II
PML
$486M
$65.5K 0.02%
4,980
TWX
431
DELISTED
Time Warner Inc
TWX
$64.8K 0.02%
634
-834
-57% -$84.6K
SKYY icon
432
First Trust Cloud Computing ETF
SKYY
$2.78B
$64.3K 0.02%
1,536
-1,149
-43% -$47K
VYM icon
433
Vanguard High Dividend Yield ETF
VYM
$81.3B
$63.9K 0.02%
788
-454
-37% -$36K
XLRN
434
DELISTED
Acceleron Pharma
XLRN
$63.4K 0.02%
1,700
BIVV
435
DELISTED
Bioverativ Inc. Common Stock
BIVV
$62.4K 0.02%
1,094
-815
-43% -$47.7K
VXF icon
436
Vanguard Extended Market ETF
VXF
$30.5B
$62.1K 0.02%
580
-6
-1% -$619
CRI icon
437
Carter's
CRI
$1.43B
$62.1K 0.02%
630
-34
-5% -$3.03K
WELL icon
438
Welltower
WELL
$175B
$61.8K 0.02%
880
-350
-28% -$25.5K
VOO icon
439
Vanguard S&P 500 ETF
VOO
$968B
$60.7K 0.02%
264
-423
-62% -$95.8K
RSPT icon
440
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.43B
$60.4K 0.02%
4,480
-7,400
-62% -$96.4K
WFT
441
DELISTED
Weatherford International plc
WFT
$59.5K 0.02%
13,000
NS
442
DELISTED
NuStar Energy L.P.
NS
$59.5K 0.02%
1,466
-1,766
-55% -$74.7K
TR icon
443
Tootsie Roll Industries
TR
$2.9B
$59.1K 0.02%
2,028
DXJ icon
444
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
$58.9K 0.02%
1,078
-11
-1% -$577
WW
445
DELISTED
WW International
WW
$58.8K 0.02%
1,350
VRP icon
446
Invesco Variable Rate Preferred ETF
VRP
$2.99B
$58K 0.02%
2,226
-24
-1% -$626
VFC icon
447
VF Corp
VFC
$6.72B
$57.6K 0.02%
962
BHC icon
448
Bausch Health
BHC
$1.67B
$57.3K 0.02%
4,000
GM icon
449
General Motors
GM
$78.7B
$57.1K 0.02%
1,416
-578
-29% -$21.1K
MLPI
450
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
$56.6K 0.02%
2,250
-6,604
-75% -$168K

Similar funds

Winslow Evans & Crocker's Q3 2017 Portfolio in Review

As of Q3 2017, Winslow Evans & Crocker held 1,314 positions worth $302M, down 17% from $365M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Winslow Evans & Crocker withdrew a net $78M in Q3 2017, closing 197 positions and reducing 571 holdings. Its most notable exit was Veeva Systems, an estimated $619K position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Winslow Evans & Crocker opened a new position in Regeneron Pharmaceuticals worth $358K.

  • Winslow Evans & Crocker's largest Q3 2017 buy was Regeneron Pharmaceuticals: 802 shares worth $358K.
  • Winslow Evans & Crocker added most to Deere & Co in Q3 2017, an estimated $481K increase.
  • Winslow Evans & Crocker's biggest Q3 2017 reduction was Microsoft, cutting an estimated $2.03M.
  • Winslow Evans & Crocker fully exited Veeva Systems in Q3 2017, selling an estimated $619K.
  • Winslow Evans & Crocker's ten largest holdings make up 22% of its $302M portfolio in Q3 2017.
  • Winslow Evans & Crocker opened 44 new positions and closed 197 in Q3 2017.
  • Winslow Evans & Crocker's portfolio value fell 17% quarter-over-quarter to $302M.

Based on Winslow Evans & Crocker's 13F filing for Q3 2017, filed 19 Oct 2017.